Vitamin E Shows Decline In Alzheimer’s - John Gever
Taking vitamin E supplements may delay declines in daily functioning experienced by patients with mild to moderate Alzheimer’s disease, a new study revealed in the Journal of the American Medical Association, published on January 1. Study co-author Mary Sano, PhD <http://www.mountsinai.org/profiles/mary-sano> , Director of the Alzheimer’s Disease Research Center at the Icahn School of Medicine at Mount Sinai, said that study results were robust enough to warrant a recommendation that patients with mild to moderate Alzheimer's disease start taking vitamin E supplements. She pointed out that the results, in addition to demonstrating a functional benefit for vitamin E, also indicated that it was safe, at least in terms of mortality -- in contrast to a 2005 meta-analysis <http://www.ncbi.nlm.nih.gov/pubmed/15537682> that suggested higher death rates for people taking vitamin E supplements.
- Dr. Mary Sano, Associate Dean for Clinical Research, Professor, Psychiatry, Director of the Alzheimer’s Disease Research, Icahn School of Medicine at Mount Sinai
Learn more
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases
Mount Sinai Launches Institute for Regenerative Medicine
Apr 24, 2023 View All Press Releases
